Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Altamira Therapeutics Ltd (NQ: CYTO )

0.5000 +0.0161 (+3.33%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Altamira Therapeutics Ltd

< Previous 1 2 3 4 5 6 7 8 9 Next >
RNA Therapies Hold The Power To Transform Treatment For Numerous Ailments, But Delivering These Remains Problematic – Will This Biotech Change That?
Thomas Meyer, CEO of Altamira Therapeutics (NASDAQ: CYTO), was recently a guest on Benzinga’s All-Access. 
Via Benzinga
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results. 
Via Benzinga
Why Volcon Shares Are Trading Lower By 19%; Here Are 20 Stocks Moving Premarket
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares rose 38.7% to $0.1421 in pre-market trading after gaining 10% on Thursday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! 
Via InvestorPlace
Altamira Therapeutics Reports Additional Significant Efficacy Outcomes from Bentrio Clinical Trial in Seasonal Allergic Rhinitis
From Altamira Therapeutics Ltd
Via GlobeNewswire
Altamira Therapeutics Provides Business Update and First Half 2023 Financial Results
From Altamira Therapeutics Ltd
Via GlobeNewswire
Earnings Scheduled For September 12, 2023
Companies Reporting Before The Bell • Root (NASDAQ:ROOT) is projected to report quarterly loss at $0.10 per share on revenue of $48.95 million. 
Via Benzinga
Altamira Therapeutics to Host First Half 2023 Financial Results and Business Update Call on September 12th
From Altamira Therapeutics Ltd
Via GlobeNewswire
Altamira Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13
From Altamira Therapeutics Ltd
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 56 companies set new 52-week lows. 
Via Benzinga
Altamira Therapeutics and Pharma Nordic Collaborate for Marketing and Distribution of Bentrio in Scandinavia
From Altamira Therapeutics Ltd
Via GlobeNewswire
Altamira Therapeutics Announces Publication of Positive Results from Clinical Trial with Bentrio in House Dust Mite Allergy in Leading Peer Reviewed Journal
From Altamira Therapeutics Ltd
Via GlobeNewswire
Why Altamira Therapeutics (CYTO) Stock Is Getting Hammered
Altamira Therapeutics Ltd (NASDAQ: CYTO) shares are trading lower by 19.23% to $0.44 Thursday morning after the company announced pricing of a $5 million public offer 
Via Benzinga
Altamira Therapeutics Announces Pricing of $5.0 Million Public Offering
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day off right with a breakdown of the biggest pre-market stock movers traders need to watch on Thursday! 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday's session saw 43 companies set new 52-week lows. 
Via Benzinga
Altamira Therapeutics Announces Collaboration with Heqet Therapeutics on Nanoparticle-Delivered Non-Coding RNAs for Cardiac Regeneration
From Altamira Therapeutics Ltd
Via GlobeNewswire
Altamira Therapeutics Announces IND Clearance by U.S. FDA for AM-125 in Acute Vestibular Syndrome
Via ACCESSWIRE
Altamira Therapeutics Announces Publication of Peer-Reviewed Article on Peptide-Based RNA Delivery for Extrahepatic Targets
Via ACCESSWIRE
Altamira Therapeutics Reports Positive Top-Line Data from Bentrio Clinical Trial in Seasonal Allergic Rhinitis
Via ACCESSWIRE
Altamira Therapeutics Provides Business Update, Reports FY 2022 Financial Results
Via ACCESSWIRE
Altamira Therapeutics to Host Fiscal Year 2022 Financial Results and Business Update Call on May 16th 2023
Via ACCESSWIRE
Why Carvana Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning! We're diving into the biggest pre-market stock movers traders will want to keep an eye on for Friday morning! 
Via InvestorPlace
Why Is PacWest Bancorp (PACW) Stock Down 38% Today?
PacWest Bank (PACW) stock is falling hard on Thursday after the financial company said it's exploring strategic options. 
Via InvestorPlace
Why Is First Horizon (FHN) Stock Down 43% Today?
First Horizon (FHN) stock is taking a beating on Thursday after the company failed to complete its merger with TD Bank (TD). 
Via InvestorPlace
Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 89.3% to $7.44. 
Via Benzinga
Why Arconic Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
Gainers Almaden Minerals Ltd. (NYSE: AAU) gained 72.3% to $0.2111 in pre-market trading after gaining 2% on Wednesday. 
Via Benzinga
Why Is Arconic (ARNC) Stock Up 28% Today?
Arconic (ARNC) stock is on the rise Thursday following news that the company is being acquired by Apollo Global Management (APO). 
Via InvestorPlace
Why Is Altamira Therapeutics (CYTO) Stock Up 45% Today?
Altamira Therapeutics (CYTO) stock is taking off on Thursday despite a lack of news from the RNA-based therapeutics company. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.